PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Yes AGM preso confirmed peer review was key deliverable for...

  1. 9,839 Posts.
    lightbulb Created with Sketch. 1258
    Yes AGM preso confirmed peer review was key deliverable for FY24:

    "OA manuscript following Day 56 & Day 168 PARA_OA_008 readout, detailing biomarker and clinical outcomes completed for peer review and publishing.
    • Manuscripts being completed to include significant data recently released detailing structural improvement by quantitative MRI analysis."
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.